Posted on 6/7/18
Generation Bio Appoints Jeff Jonas M.D. to its Board of Directors
Generation Bio, a company developing the first genetic medicines that can be titrated to effect and re-dosed for a lifetime of benefit
Posted on 6/7/18
Zafgen Appoints Dr. Wendy Everett To Board
Zafgen, Inc., (Nasdaq:ZFGN), a clinical-stage biopharmaceutical company leveraging its proprietary MetAP2 biology platform to develop novel therapies for patients affected
Posted on 6/6/18
B.GOOD Appoints Chris Fuqua as New CEO
B.GOOD, the industry pioneer in providing great tasting, locally sourced burgers, bowls, salads and smoothies, today announced the appointment of Chris Fuqua
Posted on 6/6/18
Rubius Therapeutics Appoints Pablo J. Cagnoni, M.D. as Chief Executive Officer
Rubius Therapeutics, a biotechnology company pioneering the development of a new class of ready-to-use cellular therapies, today announced the appointment of Pablo J. Cagnoni, M.D.
Posted on 6/6/18
Corbus Pharmaceuticals Appoints Former Director of FDA Office of New Drugs John K. Jenkins, MD To Board
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP), a Phase 3 clinical-stage pharmaceutical company focused on the development and commercialization
Posted on 6/6/18
Abry Partners-backed FLS Names John Leach as CEO
FLS Transportation Services Limited, one of North-America’s leading Third Party Logistics (3PL) firms, is delighted to announce the appointment of John Leach as Chief Executive Officer . . .
Posted on 6/6/18
Anthony J. Guzzi Elected Chairman of the Board of Directors of Emcor Group
EMCOR Group, Inc. (NYSE:EME) today announced that its Board of Directors elected Anthony J. Guzzi, President and Chief Executive Officer of EMCOR
Posted on 6/5/18
Oliver Luck Named XFL Commissioner & CEO
STAMFORD, Conn.--(BUSINESS WIRE)--The XFL today announced that former NFL and NCAA executive and quarterback Oliver Luck has been named the league’s Commissioner & CEO. The new . . .
Posted on 6/5/18
BIO Elects New Board Directors and Section Governing Board Chairs
The Biotechnology Innovation Organization (BIO) is pleased to announce the election of 11 new board directors and several new section governing board chairs
Posted on 6/5/18
Akcea Therapeutics Appoints Dr. Richard Moscicki to Board of Directors
Akcea Therapeutics, Inc. (NASDAQ:AKCA), an affiliate of Ionis Pharmaceuticals, Inc., today announced the appointment of Richard (Rich) A. Moscicki, M.D.,
Posted on 6/5/18
Ernst & Young LLP Announces Nelipak CEO Mike Kelly as Entrepreneur of the Year 2018 Award Finalist for New England Region
BOSTON, June 04, 2018 (GLOBE NEWSWIRE) -- EY today announced that Mike Kelly, president and CEO of Nelipak®Healthcare Packaging, a full-service global provider of custom thermoformed packaging . . .
Posted on 6/5/18
Collegium Appoints Joseph Ciaffoni as CEO
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) today announced that Joseph Ciaffoni, Executive Vice President and Chief Operating Officer
Posted on 6/4/18
AOBiome Therapeutics Elects Dr. Jun Wang as Chairman of the Board of Directors
AOBiome Therapeutics, a world-leading clinical-stage microbiome company focusing on research and development of therapeutics for inflammatory conditions
Posted on 6/4/18
CounterTack Appoints Robert J. McCullen Executive Chairman
CounterTack, the leading provider of Predictive Endpoint Detection and Response (EDR) platform and Next Generation Antivirus (NGAV) for the enterprise
Posted on 6/4/18
Tiba Biotech Appoints Dr. Christian W. Mandl as Chairman of Company’s Scientific Advisory Board
Tiba Biotech, a pre-clinical biotechnology company developing next generation RNA vaccines for human and animal health
Posted on 6/3/18
Amorsa Therapeutics Appoints Jeffrey Wiesen to Board of Directors
Amorsa Therapeutics Inc., a neuropharmaceutical company pioneering the development of breakthrough treatments for nervous system disorders
Posted on 5/31/18
Bicycle Therapeutics Announces Formation of Scientific Advisory Board
Bicycle Therapeutics, a biotechnology company pioneering a new class of therapeutics based on its proprietary bicyclic peptide product platform
Posted on 5/31/18
Axcella Appoints Bill Hinshaw as President and Chief Executive Officer
Axcella Health, a biotechnology company pioneering a new class of products to rebalance patients’ metabolic state to address serious unmet medical needs
Posted on 5/31/18
Kevin Haverty Joins Drift’s Board of Directors
Drift, the world’s leading conversational marketing and sales platform, today announced that enterprise sales leader Kevin Haverty has been elected to Drift’s board of directors.
Posted on 5/31/18
Platelet BioGenesis Appoints Leading Hematology Experts and Physicians to Its Scientific Advisory Board
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Platelet BioGenesis, the leader in the production of functional human platelets (PLTs+TM) from stem cells and the development of platelet-based therapeutics, announced it has . . .
Posted on 5/31/18
GNS Healthcare Names Ted Goldstein to its Strategic Advisory Board
GNS Healthcare (GNS), a leading precision medicine company, announced the appointment of Dr. Ted Goldstein, Scientific Program Director of Computational Health
Posted on 5/31/18
EY Names Flywire CEO Entrepreneur of the Year Finalist in New England
BOSTON, May 31, 2018 (GLOBE NEWSWIRE) -- EY has selected Mike Massaro, CEO of global payment and receivables solutions provider Flywire, as a finalist for the . . .
Posted on 5/31/18
Eliassen Group CEO David MacKeen Named a Finalist for the EY Entrepreneur of the Year 2018 Award in the New England Region
EY recently announced that David MacKeen, CEO of Eliassen Group, is a finalist for the Entrepreneur of the Year 2018 Award in the New England region. . . .
Posted on 5/30/18
Immunology and Cancer Research Leaders Join Elstar Therapeutics’ Scientific Advisory Board
Elstar Therapeutics, a company fulfilling the promise of precision cancer immunotherapy through a powerful new approach to generating multi-functional therapies
Posted on 5/29/18
Elektrofi Appoints Leading Scientists and Biotech Entrepreneurs to New Board of Advisors
Elektrofi, Inc., a Boston based biotechnology company focused on drug formulation innovations, announced today that it has appointed a distinguished group of leading scientists
Boston
